Company news
Biostax Corp. news in 2017
Biostax Corp.'s news releases, calls and decks from 2017, newest first.
Immune Therapeutics, Inc. Shareholder Update Letter
November 30, 2017
Immune Therapeutics, Inc. Announces Exclusive Agreement for Sale of Lodonal in Kenya Valued at Over $31 Million
September 6, 2017
Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million
September 6, 2017
Immune Therapeutics, Inc. Appoints John H. Abeles, M.D. as Chairman and CEO of Company’s Subsidiary, Cytocom, Inc. and as Senior Adviser to Immune Therapeutics, Inc.
August 23, 2017
Immune Therapeutics to Present at the 7th Annual LD Micro Invitational
June 4, 2017
Immune Therapeutics Signs Memorandum of Understanding for Distribution of Lodonal™ in Côte d’Ivoire and acquires COPP for Côte d’Ivoire; Company Plans for Approval of Lodonal in Côte d’Ivoire in 201
May 31, 2017
CORRECTING and REPLACING: Immune Therapeutics, Inc.
May 22, 2017
Immune Therapeutics Announces NAFDAC Approval of Lodonal™ for the Treatment of HIV in Nigeria
May 22, 2017
Immune Therapeutics, Inc. Files Lodonal New Drug Application in Kenya
April 25, 2017
Immune Therapeutics Clears Critical Regulatory Hurdle for Lodonal in Kenya
April 17, 2017
Immune Therapeutics, Inc. Strengthens Balance Sheet With Debt Settlement
April 12, 2017
Immune Therapeutics, Inc. Announces Expansion of Patent Portfolio
March 30, 2017
Immune Therapeutics, Inc. Further Strengthens Balance Sheet as it Prepares for Commercialization
March 15, 2017
IMMUNE THERAPEUTICS STRENGTHENS BALANCE SHEET; Reiterates Outlook for Positive Cash Flow by Mid Year
February 9, 2017
Immune Therapeutics Clears Critical Certification Milestone
February 2, 2017
UPDATE -- Immune Therapeutics Issues Special Letter to Shareholders
January 30, 2017
Immune Therapeutics Issues Special Letter to Shareholders
January 30, 2017
Immune Therapeutics Announces Special Investor Conference Call to Discuss 2017 Outlook
January 27, 2017
Immune Therapeutics Retains Investor Relations Partners to Support Company’s Strategic IR Program as it Prepares for Commercialziation
January 26, 2017